ORAMED PHARMACEUTICALS INC. (ORMP) Stock Profile — Insider Trades & Financials

Revenue$0

Net Income$10.0M

EPS$0.24

Market Cap$158.7M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Nadav Kidron

CEO & Executive Director

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

Founded: 2002
Employees: 4
Headquarters: NEW YORK, NY, United States
Website: www.oramed.com

⚡

Core Efficiency

ROE?

5.01%

ROA?

4.34%

📊

Profitability Ratios

Current Ratio?

6.98

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Jun 16, 2026 (in 21 days)

Annual Report (10-K) — Based on filing pattern

Jun 16, 2026

Predicted10-K

Mar 26, 2026

10-KQ4 202585d after period end

Mar 26, 2026

10-KFY 202585d after period end

Nov 13, 2025

10-QQ3 202544d after period end

Aug 14, 2025

10-QQ2 202545d after period end

May 15, 2025

10-QQ1 202545d after period end

Mar 27, 2025

10-KFY 202586d after period end

Mar 6, 2024

10-KFY 202466d after period end

Mar 6, 2023

10-KFY 202365d after period end

Loading company sections...

ORAMED PHARMACEUTICALS INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Recent Congress Trades

The morning brief, before the bell.

ORAMED PHARMACEUTICALS INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Recent Congress Trades